Effectiveness and Tolerability of CGRP Monoclonal Antibodies vs OnabotulinumtoxinA in Patients With Chronic Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan
Eur. J. Neurol. 2024 Sep 01;31(9)e16372, YF Wang, FC Yang, LA Chen, TY Chang, HC Su, CP Yang, YH Tu, YS Tzeng, SP Chen, JL Fuh, KL Lai, YH Ling, WT Chen, SJ WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.